These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23406295)

  • 1. Boston type 1 keratoprosthesis outcomes in ocular burns.
    Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
    Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
    Cade F; Grosskreutz CL; Tauber A; Dohlman CH
    Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modified Cincinnati procedure: combined conjunctival limbal autografts and keratolimbal allografts for severe unilateral ocular surface failure.
    Chan CC; Biber JM; Holland EJ
    Cornea; 2012 Nov; 31(11):1264-72. PubMed ID: 22406944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.
    Kosker M; Suri K; Rapuano CJ; Ayres BD; Nagra PK; Raber IM; Hammersmith KM
    Cornea; 2015 Sep; 34(9):1057-62. PubMed ID: 26114818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of penetrating keratoplasty after autologous cultivated limbal epithelial transplantation for ocular surface burns.
    Basu S; Mohamed A; Chaurasia S; Sejpal K; Vemuganti GK; Sangwan VS
    Am J Ophthalmol; 2011 Dec; 152(6):917-924.e1. PubMed ID: 21851920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes and complications of Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis following ocular surface burns: clinical experience in China.
    Wang L; Huang Y; Du G; Dong Y; Guo H; Wang D; Yu J; Wang Q; Chen B; Hou L
    Br J Ophthalmol; 2015 Dec; 99(12):1669-74. PubMed ID: 26034080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston type 1 keratoprosthesis for chemical and thermal injury.
    Phillips DL; Hager JL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Cornea; 2014 Sep; 33(9):905-9. PubMed ID: 25055151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of repeat autologous cultivated limbal epithelial transplantation for ocular surface burns.
    Basu S; Ali H; Sangwan VS
    Am J Ophthalmol; 2012 Apr; 153(4):643-50, 650.e1-2. PubMed ID: 22265153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes with Boston type 1 keratoprosthesis in ocular burns.
    Magalhães FP; Hirai FE; Sousa LB; Oliveira LA
    Arq Bras Oftalmol; 2018 Jun; 81(3):177-182. PubMed ID: 29924191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study of Boston keratoprosthesis in treatment of severe late stage ocular chemical burns].
    Chen JQ; Zhai JJ; Gu JJ; Shao YF; Liu YM; Yuan J; Zhou SY
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):537-41. PubMed ID: 22943810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston Keratoprosthesis Type 1 in Chemical Burns.
    Salvador-Culla B; Kolovou PE; Arzeno L; Martínez S; López MA
    Cornea; 2016 Jun; 35(6):911-6. PubMed ID: 27078002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.